Skip to content

Clinical trials

Phase 2 Hepatitis, Alcoholic trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hepatitis, Alcoholic Phase: Phase 2 Country / region: United Kingdom Clear all

6 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20131
20161
20191
20211
20221
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed3
Terminated2
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Conatus Pharmaceuticals Inc.1
Durect1
Gilead Sciences1
Imperial College London1
Intercept Pharmaceuticals1
Yaqrit Ltd1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hepatitis, Alcoholic6
Fibrosis2
Liver Diseases2
Acute-On-Chronic Liver Failure1
Alcoholism1
Hepatitis1
Jaundice1
Liver Cirrhosis1
Liver Cirrhosis, Alcoholic1
Liver Failure1

Trials

Showing 1 to 6 of 6. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.